The undertakings concerned should be granted the possibility of requesting referrals to or from the Commission before a concentration is notified so as to further improve the efficiency of the system for the control of concentrations within the Community. In such situations, the Commission and national competition authorities should decide within short, clearly defined time limits whether a referral to or from the Commission ought to be made, thereby ensuring the efficiency of the system. Upon request by the undertakings concerned, the Commission should be able to refer to a Member State a concentration with a Community dimension which may significantly affect competition in a market within that Member State presenting all the characteristics of a distinct market; the undertakings concerned should not, however, be required to demonstrate that the effects of the concentration would be detrimental to competition. A concentration should not be referred from the Commission to a Member State which has expressed its disagreement to such a referral. Before notification to national authorities, the undertakings concerned should also be able to request that a concentration without a Community dimension which is capable of being reviewed under the national competition laws of at least three Member States be referred to the Commission. Such requests for pre-notification referrals to the Commission would be particularly pertinent in situations where the concentration would affect competition beyond the territory of one Member State. Where a concentration capable of being reviewed under the competition laws of three or more Member States is referred to the Commission prior to any national notification, and no Member State competent to review the case expresses its disagreement, the Commission should acquire exclusive competence to review the concentration and such a concentration should be deemed to have a Community dimension. Such pre-notification referrals from Member States to the Commission should not, however, be made where at least one Member State competent to review the case has expressed its disagreement with such a referral.
Recital 16, Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations…
Judgment of the General Court (Third Chamber, Extended Composition) of 13 July 2022. Illumina, Inc. v European Commission.Decision
The respective conditions for the application of those two provisions are fundamentally different, since the first expressly provides that the concentration which is the subject of the referral must be ‘capable of being reviewed under …
13 Jul 2022 · 62021TJ0227
Opinion of Advocate General Emiliou delivered on 21 March 2024. Illumina Inc. and Grail LLC v European Commission.Decision
First, what is the subject matter of recital 11? Its context is important. Recital 8 clarifies the basic principles concerning the allocation of competences between the Commission and the NCAs. Recitals 9 and 10 concern the EUMR turnover …
21 Mar 2024 · 62022CC0611
Judgment of the Court (Grand Chamber) of 3 September 2024. Illumina, Inc. v European Commission.Decision
In addition, the General Court held, in paragraphs 145 to 147 of the judgment under appeal, that recitals 15 and 16 of Regulation No 139/2004 support the finding that the conditions for the application of the referral mechanism provided …
3 Sep 2024 · 62022CJ0611